749 related articles for article (PubMed ID: 19697403)
1. Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.
Tebit DM; Sangaré L; Tiba F; Saydou Y; Makamtse A; Somlare H; Bado G; Kouldiaty BG; Zabsonre I; Yameogo SL; Sathiandee K; Drabo JY; Kräusslich HG
J Med Virol; 2009 Oct; 81(10):1691-701. PubMed ID: 19697403
[TBL] [Abstract][Full Text] [Related]
2. Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso.
Nadembega WM; Giannella S; Simpore J; Ceccherini-Silberstein F; Pietra V; Bertoli A; Pignatelli S; Bellocchi MC; Nikiema JB; Cappelli G; Bere A; Colizzi V; Perno CP; Musumeci S
J Med Virol; 2006 Nov; 78(11):1385-91. PubMed ID: 16998878
[TBL] [Abstract][Full Text] [Related]
3. Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naive patients in Estonia.
Avi R; Huik K; Sadam M; Karki T; Krispin T; Ainsalu K; Paap P; Schmidt J; Nikitina N; Lutsar I
J Med Virol; 2009 Jun; 81(6):953-8. PubMed ID: 19382254
[TBL] [Abstract][Full Text] [Related]
4. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
[TBL] [Abstract][Full Text] [Related]
5. Molecular diversity and polymerase gene genotypes of HIV-1 among treatment-naïve Cameroonian subjects with advanced disease.
Soares EA; Makamche MF; Siqueira JD; Lumngwena E; Mbuagbaw J; Kaptue L; Asonganyi T; Seuánez HN; Soares MA; Alemnji G
J Clin Virol; 2010 Jul; 48(3):173-9. PubMed ID: 20483657
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
Cardoso LP; Queiroz BB; Stefani MM
J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil.
Cardoso LP; Pereira GA; Viegas AA; Schmaltz LE; Stefani MM
J Med Virol; 2010 Mar; 82(3):351-7. PubMed ID: 20087934
[TBL] [Abstract][Full Text] [Related]
8. High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance.
Pérez-Alvarez L; Carmona R; Muñoz M; Delgado E; Thomson MM; Contreras G; Pedreira JD; Rodríguez Real R; Vázquez de Parga E; Medrano L; Taboada JA; Nájera R;
Antivir Ther; 2003 Aug; 8(4):355-60. PubMed ID: 14518705
[TBL] [Abstract][Full Text] [Related]
9. Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006.
Derache A; Maiga AI; Traore O; Akonde A; Cisse M; Jarrousse B; Koita V; Diarra B; Carcelain G; Barin F; Pizzocolo C; Pizarro L; Katlama C; Calvez V; Marcelin AG
J Antimicrob Chemother; 2008 Sep; 62(3):456-63. PubMed ID: 18556706
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.
Babic DZ; Zelnikar M; Seme K; Vandamme AM; Snoeck J; Tomazic J; Vidmar L; Karner P; Poljak M
Virus Res; 2006 Jun; 118(1-2):156-63. PubMed ID: 16417938
[TBL] [Abstract][Full Text] [Related]
11. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
[TBL] [Abstract][Full Text] [Related]
12. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
Ferreira AS; Cardoso LP; Stefani MM
J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
[TBL] [Abstract][Full Text] [Related]
13. Genotypic resistance profiles in antiretroviral-naive HIV-1 infections before and after initiation of first-line HAART: impact of polymorphism on resistance to therapy.
Sukasem C; Churdboonchart V; Sukeepaisarncharoen W; Piroj W; Inwisai T; Tiensuwan M; Chantratita W
Int J Antimicrob Agents; 2008 Mar; 31(3):277-81. PubMed ID: 18182278
[TBL] [Abstract][Full Text] [Related]
14. Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
Derache A; Traore O; Koita V; Sylla A; Tubiana R; Simon A; Canestri A; Carcelain G; Katlama C; Calvez V; Cisse M; Marcelin AG
Antivir Ther; 2007; 12(1):123-9. PubMed ID: 17503757
[TBL] [Abstract][Full Text] [Related]
15. Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.
Bellocchi MC; Forbici F; Palombi L; Gori C; Coelho E; Svicher V; D'Arrigo R; Emberti-Gialloreti L; Ceffa S; Erba F; Marazzi MC; Silberstein FC; Perno CF
J Med Virol; 2005 Aug; 76(4):452-8. PubMed ID: 15977236
[TBL] [Abstract][Full Text] [Related]
16. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC
Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504
[TBL] [Abstract][Full Text] [Related]
17. Characterization of drug resistance in antiretroviral-treated patients infected with HIV-1 CRF02_AG and AGK subtypes in Mali and Burkina Faso.
Sylla M; Chamberland A; Boileau C; Traoré HA; Ag-Aboubacrine S; Cissé M; Koala S; Drabo J; Diallo I; Niamba P; Tremblay-Sher D; Machouf N; Rashed S; Nickle DC; Nguyen VK; Tremblay CL;
Antivir Ther; 2008; 13(1):141-8. PubMed ID: 18389909
[TBL] [Abstract][Full Text] [Related]
18. Detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast Brazil.
Santos LA; Monteiro-Cunha JP; Araujo AF; Brites C; Galvao-Castro B; Alcantara LC
J Med Virol; 2011 Dec; 83(12):2066-72. PubMed ID: 22012712
[TBL] [Abstract][Full Text] [Related]
19. Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors.
Brenner BG; Lowe M; Moisi D; Hardy I; Gagnon S; Charest H; Baril JG; Wainberg MA; Roger M
J Med Virol; 2011 May; 83(5):751-9. PubMed ID: 21360548
[TBL] [Abstract][Full Text] [Related]
20. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
